证券日报网讯 1月16日，艾比森在互动平台回答投资者提问时表示，2025年度公司预计实现营业收入约 为41.56亿元，同比2024年上升约13.46%。其中：海外市场经过多年的持续深耕与科学布局，进一步深 化本地化运营，构建起高效协同的全球渠道网络，打造出差异化的品牌优势，显著增强了在国际市场的 竞争力。海外市场预计实现营业收入约31.93亿元，同比增长约8.94%，继续保持良好增长态势。国内市 场在LED显示整体需求疲软的背景下，通过聚焦优质客户、优化产品结构、调整渠道策略等关键举措， 预计实现营业收入约9.63亿元，同比增长约31.56%，成功实现逆势增长。更多详情请参阅已披露的业绩 预告。 （文章来源：证券日报） ...

声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 有投资者在互动平台向艾比森提问："看公司业绩预告增长还不错，2025年营收增长的主要动能来自哪 里？" 作者：公告君 针对上述提问，艾比森回应称："投资者您好，2025年度公司预计实现营业收入约为41.56亿元，同比 2024年上升约13.46%。其中：海外市场经过多年的持续深耕与科学布局，进一步深化本地化运营，构 建起高效协同的全球渠道网络，打造出差异化的品牌优势，显著增强了在国际市场的竞争力。海外市场 预计实现营业收入约31.93亿元，同比增长约8.94%，继续保持良好增长态势。国内市场在LED显示整体 需求疲软的背景下，通过聚焦优质客户、优化产品结构、调整渠道策略等关键举措，预计实现营业收入 约9.63亿元，同比增长约31.56%，成功实现逆势增长。更多详情请参阅已披露的业绩预告，感谢您的关 注！" 本文源自：市场资讯 ...

43家创业板公司2025年度业绩预告亮相，业绩预增公司有22家，占比51.16%。 技 （文章来源：证券时报网） 创业板业绩预计暴增股名单 | 代码 | 简称 | 业绩预告日 | 预计净利润增幅中值 | 最新收盘价 | 今年以来涨跌 | 行业 | | --- | --- | --- | --- | --- | --- | --- | | | | 期 | （%） | （元） | （%） | | | 300871 | 回盛生 | 2026.01.09 | 1355.24 | 25.52 | 23.11 | 农林牧 | | | 物 | | | | | 渔 | | 300435 | 中泰股 | 2026.01.06 | 677.22 | 29.14 | 31.14 | 公用事 | | | 份 | | | | | 业 | | 300138 | 晨光生 | 2026.01.13 | 301.38 | 13.78 | 11.04 | 农林牧 | | | 物 | | | | | 渔 | | 300773 | 拉卡拉 | 2026.01.13 | 222.00 | 32.08 | 12.64 | 非银金 融 | | | 大族数 ...

艾比森(300389)1月13日公告，公司控股股东、实控人、董事长丁彦辉原拟通过集中竞价、大宗交易的 方式减持公司股份不超过1107.3万股（占公司总股本的3%）。截至公告日，丁彦辉已减持400股。基于 对公司持续稳定发展的信心，丁彦辉决定提前终止减持计划，剩余未减持股份在本次减持计划期限内不 再减持。 ...

本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一 致。 深圳市艾比森光电股份有限公司（以下简称"艾比森"或"公司"）于 2025 年 10 月 24 日在巨潮资讯网披露了《关于控股股东、实际控制人减持股份的预披 露公告》（公告编号：2025-059）。公司控股股东、实际控制人、董事长丁彦辉 先生拟通过集中竞价、大宗交易的方式减持其持有的公司股份不超过 11,073,009 股（含本数），即不超过预披露公告披露之日公司股份总数的 3%。 公司于近日收到丁彦辉先生出具的《关于股份减持计划提前结束的告知函》， 截至目前，丁彦辉先生已减持股份 400 股，本次减持计划提前结束，剩余未减持 股份在本次减持计划期限内不再减持。现将具体情况公告如下： 一、股东减持基本情况 证券代码：300389 证券简称：艾比森 公告编码：2026-003 深圳市艾比森光电股份有限公司 关于控股股东、实际控制人股份减持计划提前终止的公告 公司控股股东、实际控制人、董事长丁彦辉先生保证向本公司提供的信息 内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 | 股东 | 股份性质 | | 本次减持前持有股份 | 持有股份 ...

证券日报网讯1月13日，艾比森（300389）在互动平台回答投资者提问时表示，公司的全资子公司艾比 森投资公司对睿电绿能等进行投资并持有相应的股权，相关事项已按规定履行披露义务，睿电绿能主要 开展新能源储能业务，致力于为客户提供安全的、智能的、可持续的绿色储能产品和服务，业务涵盖家 庭储能和工商业储能领域，依托母公司全球市场布局优势，储能产品销售及服务网络先后触达欧洲、亚 太及国内市场，已在国内外成功交付多个商用项目。 ...

Core Insights - Approximately 130 A-share companies have disclosed their performance forecasts for 2025, with around 70 companies expecting positive results, including profit increases and turnaround from losses [2][4]. Company Performance Highlights - **Zhongke Lanyun**: Expected net profit of 1.4 billion to 1.43 billion yuan, a year-on-year increase of 366.51% to 376.51%, driven by strategic investments in high-growth areas like GPU and advanced packaging [4][5]. - **Chuanhua Zhili**: Forecasted net profit of 540 million to 700 million yuan, with a growth rate of 256.07% to 361.57%, supported by optimized marketing strategies and asset structure in logistics and chemical businesses [5]. - **Bai'ao Saitou**: Anticipated net profit of 135 million yuan, reflecting a 303.57% increase, attributed to favorable market conditions [4]. - **Kangchen Pharmaceutical**: Expected net profit of 145 million to 175 million yuan, with a growth of 243% to 315%, due to the absence of goodwill impairment losses in the reporting period [5]. - **Guangku Technology**: Projected net profit of 169 million to 182 million yuan, a growth of 152% to 172%, driven by product innovation and cost control [7]. - **Lixun Precision**: Forecasted net profit of 16.518 billion to 17.186 billion yuan, with a growth of 23.59% to 28.59%, supported by innovations in manufacturing and AI integration [6]. - **Daotong Technology**: Expected net profit of 900 million to 930 million yuan, with a growth of 40.42% to 45.10%, driven by AI-driven services [6]. - **Aibisen**: Anticipated net profit of 240 million to 290 million yuan, reflecting a growth of 105.32% to 148.09%, due to increased R&D investment [7]. - **Chaohongji**: Expected net profit of 436 million to 533 million yuan, with a growth of 125% to 175%, supported by a focus on brand optimization and digital transformation [9]. - **WuXi AppTec**: Forecasted net profit of 19.151 billion yuan, with a growth of approximately 102.65%, including gains from divesting joint ventures [9]. - **Hui Sheng Biological**: Expected net profit of 23.5 million to 27.1 million yuan, indicating a turnaround, driven by market expansion and improved production efficiency [9]. Industry Performance Insights - The electronics, semiconductor, pharmaceutical, and machinery sectors are showing strong performance among listed companies [3].

经济观察网1月9日，"行稳致远道阻且长"2026艾比森（300389）蜂巢年会在深圳举办，采用线下+全球 直播形式，汇聚600余位全球嘉宾。2025年艾比森业绩亮眼，归母净利润预增105-148%，经营性现金流 增长约440%，显示业务签单47.6亿元，品牌价值达166.72亿元，斩获"国际信誉品牌"等荣誉。会上，董 事长丁彦辉提出四维发展战略，以"聚焦机制优化、强化团队建设、明晰目标路径、锚定核心根基"四大 维度深刻剖析在当前市场环境下企业高质量发展的核心逻辑，他强调，"走得稳，才能走得远，做企业 就像马拉松式的接力赛，要比谁走得更远、更持久。"总裁丁崇彬在会上也明确2026年68亿元签单目 标，将深化"大平台+小前端"模式。未来艾比森将聚焦LED显示主航道，以客户为中心，打造商业文明 标杆。 ...

Core Viewpoint - The company, Absen (300389.SZ), has reported strong performance for 2025, exceeding market expectations with significant revenue and profit growth driven by domestic and international market opportunities, product optimization, and operational efficiency [1][4]. Group 1: Financial Performance - For 2025, Absen expects revenue of 4.156 billion yuan, a year-on-year increase of 13.46% [1][4]. - The projected net profit attributable to shareholders is between 240 million and 290 million yuan, representing a substantial increase of 105.32% to 148.09% compared to the previous year's 117 million yuan [1][4]. - The company anticipates a non-recurring net profit of 219 million to 269 million yuan, reflecting a growth of 188.35% to 254.23% year-on-year [4][5]. - The gross profit margin for 2025 is expected to be around 31%, an increase of 3.5 percentage points from 2024 [5]. Group 2: Market Dynamics - Absen's overseas revenue is projected to be approximately 3.193 billion yuan, a year-on-year growth of about 8.94%, accounting for approximately 76.83% of total revenue [1][4]. - The domestic market is expected to generate around 963 million yuan in revenue, with a year-on-year increase of approximately 31.56% despite overall weak demand in the LED display sector [5]. Group 3: Research and Development - From 2021 to the first three quarters of 2025, Absen's cumulative R&D expenses reached 698 million yuan, reinforcing its technological barriers [2][7]. - The company has maintained a consistent R&D investment strategy, with R&D expenses as a percentage of annual revenue ranging from 4.17% to 4.63% over the past five years [7]. - As of June 2025, Absen has applied for over 1,300 intellectual property rights globally, with 30% being invention patents, supporting its competitive edge in advanced technologies [7]. Group 4: Asset Growth and Capital Operations - As of the end of the third quarter of 2025, Absen's total assets reached a historical high of 4.301 billion yuan, an increase of 18.48% year-on-year [2][6][8]. - The company plans to raise up to 360 million yuan through a private placement to enhance liquidity and optimize its capital structure [8]. - Absen's total assets have grown from 2.121 billion yuan at the end of 2020 to 3.673 billion yuan at the end of 2024, marking a 73.17% increase during this period [8]. Group 5: Market Recognition - The capital market has recognized Absen's growth potential, with the company's stock price increasing by 56.14% throughout 2025 [9]. - As of January 9, 2026, Absen's stock closed at 17.51 yuan per share, reflecting a year-to-date increase of 7.89% and a total market capitalization of 6.463 billion yuan [9].

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 证券代码：300389 证券简称：艾比森 公告编码：2026-002 深圳市艾比森光电股份有限公司 关于完成工商变更登记的公告 深圳市艾比森光电股份有限公司（以下简称"公司"）于 2025 年 11 月 7 日 召开的 2025 年第四次临时股东大会审议通过了《关于变更注册资本及修订<公司 章程>的议案》，公司于近日在深圳市市场监督管理局完成了工商变更登记及备 案手续，领取了《登记通知书》。 公司本次变更后的工商登记基本信息如下： 统一社会信用代码：91440300731127582R 企业名称：深圳市艾比森光电股份有限公司 特此公告。 住所：深圳市龙岗区坂田街道雪岗路 2018 号天安云谷产业园一期 3 栋 A 座 18、19、20 层 注册资本（万元）：36,910.0317 企业类型：上市股份有限公司 法定代表人：丁彦辉 成立日期：2001 年 8 月 23 日 经营期限：永续经营 经营范围：兴办实业（具体项目另行申报）；LED 电子显示屏的研发、销 售，计算机软件开发、服务、销售（以上不含禁止、限制项目） ...